PRVA: David Mountcastle sells 24,734 shares on 07/02/2026

PRVA reporting person David Mountcastle sold common shares on multiple dates and filed related Form 144 notices.

Rhea-AI Filing Summary

PRVA reporting person David Mountcastle sold common shares on multiple dates and filed related Form 144 notices. The excerpt lists executed sales: 7,179 shares on 05/01/2026 for $179,680.74; 1,206 shares on 05/04/2026 for $30,150.00; 3,385 shares on 05/11/2026 for $76,512.85; 17,196 shares on 06/26/2026 for $433,036.65; 24,734 shares on 07/02/2026 for $680,187.50; and 600 shares on 07/07/2026 for $16,539.00.

Insights

Corporate Governance Analyst

Multiple open-market sales by a reporting person are disclosed; filings list share counts and gross proceeds.

The excerpt lists six transactions by David Mountcastle with explicit share counts and dollar amounts tied to each trade date, providing a clear post-sale record for the period shown. The transactions are presented as executed sales with per-trade gross proceeds.

Cash-flow treatment and any trading plan or purpose are not stated in the excerpt; subsequent filings or footnotes would be required for that context.

Key Figures

Sale on 07/02/2026: 24,734 shares Proceeds on 07/02/2026: $680,187.50 Sale on 06/26/2026: 17,196 shares +3 more

6 metrics

Sale on 07/02/2026 24,734 shares trade date 07/02/2026

Proceeds on 07/02/2026 $680,187.50 gross proceeds for 24,734 shares

Sale on 06/26/2026 17,196 shares trade date 06/26/2026

Proceeds on 06/26/2026 $433,036.65 gross proceeds for 17,196 shares

Restricted stock vesting 03/11/2026 5,842 shares Restricted Stock Vesting, compensation

Total shares sold in excerpt 54,... shares Aggregate of listed trades (sum shown for context only)

Key Terms

Form 144, Restricted Stock Vesting, Issuer

3 terms

Form 144 regulatory

""144: Securities Sold During The Past 3 Months""

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

""Restricted Stock Vesting | Issuer | 5842 | 03/11/2026""

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Issuer legal

""Restricted Stock Vesting | Issuer""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What Form 144 filings does PRVA show for David Mountcastle?

The excerpt lists six reported sales by David Mountcastle across May–July 2026. It includes exact shares and gross proceeds for each trade, such as 24,734 shares on 07/02/2026 for $680,187.50, and 17,196 shares on 06/26/2026 for $433,036.65.

How many shares did David Mountcastle sell on 07/02/2026 for PRVA?

On 07/02/2026 the filing shows a sale of 24,734 shares for $680,187.50. The excerpt presents this as one of the listed transactions in the "Securities Sold During The Past 3 Months" section.

Are the proceeds from these PRVA sales specified in the filing?

Yes. Each trade in the excerpt includes a gross dollar amount alongside the share count and trade date, for example $179,680.74 for 7,179 shares on 05/01/2026. The filing shows per‑trade gross proceeds.

Do the filings state whether the sales were open‑market or pursuant to a trading plan?

The provided excerpt lists trade dates, share counts, and proceeds but does not state the method or whether trades were under a Rule 10b5‑1 plan. The filing text shown contains no trading‑plan language or execution method.

Does the excerpt show any restricted stock vesting for PRVA?

Yes. The excerpt records restricted stock vesting events on 03/11/2026, 03/12/2026, and 03/13/2026 with respective share counts of 5,842, 7,630, and 7,803. These are labeled as "Restricted Stock Vesting" and associated with compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/09/2026 - 05:13 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001858396
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Privia Health Group, Inc.
SEC File Number	001-40365
Address of Issuer	950 N. GLEBE RD., SUITE 700 ARLINGTON VIRGINIA 22203
Phone	571-366-8850
Name of Person for Whose Account the Securities are To Be Sold	Mountcastle David
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	21275	588602.61	126012374	07/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/11/2026	Restricted Stock Vesting	Issuer			5842	03/11/2026	Compensation
Common	03/12/2026	Restricted Stock Vesting	Issuer			7630	03/12/2026	Compensation
Common	03/13/2026	Restricted Stock Vesting	Issuer			7803	03/13/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	05/01/2026	7179	179680.74
David Mountcastle 950 N. Glebe Rd Suite 700 Arlington VA 22203	Common	05/04/2026	1206	30150.00
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	05/11/2026	3385	76512.85
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	06/26/2026	17196	433036.65
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	07/02/2026	24734	680187.50
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	07/07/2026	600	16539.00

144: Remarks and Signature

Remarks
Date of Notice	07/09/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/13/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gary Redman, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for David Mountcastle
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)